High-Throughput MSC Conditioning System for Angiogenic Phenotype
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mesenchymal stem cell (MSC) therapies for treating diseases such as cardiovascular conditions face limitations due to poor efficacy, heterogeneity within MSC populations, and reduced therapeutic potential with aging or disease, and there is a lack of high-throughput systems to effectively study the impact of mechanical forces on cellular behavior.
Innovation Solution
A high-throughput system using a modular multi-well plate format with a true linear motor applies mechanical stretch to cultured MSCs, simulating complex dynamic strain waveforms, combined with pharmacological inhibitors to enhance the expression of endothelial and pericyte markers, resulting in a mixed phenotype with increased angiogenic potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If MSCs are expanded in conventional culture, then cell quantity increases, but differentiation potential and therapeutic efficacy are reduced
Solution Approach 1:
The patent applies biomechanical conditioning parameters (cyclic strain, shear stress, mechanical compression) and biochemical parameters (growth factors, oxygen tension) to MSC cultures to maintain differentiation potential during expansion. These parameter changes enable the cells to retain therapeutic efficacy while achieving sufficient quantities for clinical use.
Solution Approach 2:
The patent implements preliminary biomechanical and biochemical conditioning of MSCs before transplantation. This preliminary action pre-differentiates or pre-conditions the cells to enhance their therapeutic potential, ensuring they maintain regenerative capabilities after expansion and transplantation.
2Loss of information
If mechanical forces are applied to study cellular behavior, then understanding of mechanobiology improves, but experimental throughput remains low
Solution Approach 1:
The patent segments the mechanical conditioning process into multiple independent parameters (cyclic strain, shear stress, compression) that can be applied simultaneously in parallel bioreactor systems. This segmentation enables high-throughput experimentation by testing multiple conditions concurrently, dramatically increasing experimental throughput while maintaining detailed mechanobiology insights.
Solution Approach 2:
The patent develops universal bioreactor platforms and standardized protocols that can apply various mechanical forces and biochemical conditions to different MSC types and disease models. This multi-functionality enables a single system to perform diverse mechanobiology studies at high throughput, reducing the need for separate experimental setups.
3Adaptability or versatility
If MSCs are harvested from patients with advanced age or chronic disorders, then autologous therapy is maintained, but differentiation potential and regenerative properties are altered
Solution Approach 1:
The patent applies enhanced biomechanical conditioning parameters (increased strain magnitude, extended duration, combined mechanical stimuli) and optimized biochemical factors to MSCs from aged or diseased patients. These parameter changes compensate for the reduced regenerative potential inherent in cells from compromised donors, restoring differentiation capacity while maintaining autologous compatibility.
Solution Approach 2:
The patent implements intensive preliminary conditioning of MSCs from aged or diseased patients before transplantation. This preliminary action includes extended exposure to mechanical forces and growth factors that rejuvenate the cells' regenerative properties, ensuring they achieve therapeutic efficacy despite their origin from compromised donors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively conditions MSCs to express a combined pericyte/endothelial phenotype with enhanced regenerative properties and angiogenic potential, overcoming the limitations of existing therapies by identifying patient-specific conditions for improved therapeutic outcomes.
Implementation Method 1
A high-throughput system using a modular multi-well plate format with a true linear motor applies mechanical stretch to cultured MSCs, simulating complex dynamic strain waveforms
Data Source
AI summary
A high-throughput screening system is provided for optimizing the conditioning of patient-specific mesenchymal stem cells using a combinatorial set of biochemical factors, pharmacological inhibitors, and biomechanical forces. Also provided are generalized conditions for performing such conditioning. Cells made by these methods are also provided, in addition to cells having a mixed endothelial cell/pericyte phenotype. These cells produce angiogenic growth factors and induce vascularization following implantation.